FDA to discuss user fees for OTC monographs

13 May 2016 - Deborah Wilkes

Archived

The US Food and Drug Administration (FDA) has announced a public meeting on the "potential development of a user-fee programme for OTC monograph drugs". The agency said it was "critically under-resourced" in this regulatory area.

Click tags below for more information on topics:

FDA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: